OncoSec Medical Inc (ONCSQ)

[hschlauch]

In situ Vaccination: Potential Mechanism(s) of Action and Biomarker Development
Robert Pierce, M.D., Scientific Director, Immunopathology Core, Fred Hutchinson Cancer Research Center

Biomarkers and Immuno-Oncology World Congress 2017

http://www.biomarkerworldcongress.com/Personalized-Immunotherapy/


I think this is his new role at Fred Hutchinson:

Overview

IMMUNO-ONCOLOGY POSITION AT THE FRED HUTCHINSON CANCER RESEARCH CENTER

The Fred Hutchinson Cancer Research Center (FHCRC) is recruiting a full-time faculty member at in the Immunotherapy Integrated Research Center. The successful candidate for this position will be a prominent immuno-pathologist who is engaged in highly collaborative research, including providing analysis of tumor and tissue samples using molecular and histochemical assays to support ongoing innovative laboratory and clinical research studies. The candidate will play a major role in the development of collaborative grants and in the design and conduct of correlative studies associated with immunotherapy clinical trials.

Responsibilities

As Scientific Director of an Immunopathology Core, the candidate would direct:

-Scientific and strategic development of the Histopathology Core
-Introduction and development of new technologies for research pathology
-Expansion of a pipeline for specimen acquisition from immunotherapy
-Clinical studies Development of novel techniques in immunopathology.

https://webcache.googleusercontent.com/search?q=cache:tGiLfq_XRxsJ:https://faculty-fhcrc.icims.com/jobs/8412/full-member/job%3Fmobile%3Dtrue%26needsRedirect%3Dfalse+&cd=4&hl=en&ct=clnk&gl=us